Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety, Tolerability and Efficacy Study of Tricaprilin (AC-1202) Administered for Ninety Days in Subjects With Probable Alzheimer's Disease of Mild to Moderate Severity

NCT00142805 is registered in ClinicalTrials.gov with Cerecin as lead sponsor.

NCT NCT00142805
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00142805 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety, Tolerability and Efficacy Study of Tricaprilin (AC-1202) Administered for Ninety Days in Subjects With Probable Alzheimer's Disease of Mild to Moderate Severity
Lead sponsor
Cerecin
Phase
Phase 2
Overall status
Completed
Start date
November 4, 2004
Completion date
January 7, 2007
Enrollment
152 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease